APA (7th ed.) Citation

Jaramillo Segura, S., Hennemann, H. M., Horak, P., Teleanu, M., Heilig, C. E., Hutter, B., . . . Schlenk, R. F. (2021). Ruxolitinib is effective in the treatment of a patient with refractory T-ALL. eJHaem, 2(1), . https://doi.org/10.1002/jha2.143

Chicago Style (17th ed.) Citation

Jaramillo Segura, Sonia, et al. "Ruxolitinib Is Effective in the Treatment of a Patient with Refractory T-ALL." EJHaem 2, no. 1 (2021). https://doi.org/10.1002/jha2.143.

MLA (9th ed.) Citation

Jaramillo Segura, Sonia, et al. "Ruxolitinib Is Effective in the Treatment of a Patient with Refractory T-ALL." EJHaem, vol. 2, no. 1, 2021, https://doi.org/10.1002/jha2.143.